Bristol-Myers Squibb Company

World Rank (Jan-05-2024)

130

Market Cap (Jan-05-2024)

106.418 Billion USD

World Rank (Jul-30-2023)

100

Market Cap (Jul-30-2023)

129.010 Billion USD

World Rank (Jan-07-2022)

96

Market Cap (Jan-07-2022)

139.460 Billion USD

World Rank (Jan-01-2021)

83

Market Cap (Jan-01-2021)

140.170 Billion USD

Company Rank in Country in 2023

Rank in USA in July-2023 is 59

Headquarters Country

USA

Nasdaq / NYSE Code

BMY

Market Cap (Mar-08-2026)

122.78

CEO

Chairman

Founders

William McLaren Bristol

Employee Count

34,300

Employee Count as of Date

As on 2022

Headquarters City/State

New York

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

45,006 Million USD

Annual Operating Income in USD

8,195 Million USD

Annual Net Income in USD

8,025 Million USD

Annual Results for Period Ending

Dec-2023 ending year

Total Assets in USD

95,159 Million USD

Total Liabilities in USD

65,674 Million USD

Total Equity in USD

29,485 Million USD

Balance Sheet for Period Ending

Dec-2023 ending year

Business Sector

Company Website

Bristol-Myers Squibb - Pharmaceutical Company

Wikipedia

Yahoo

Yahoo @ NYSE

Facebook

Company Profile

Bristol-Myers Squibb is USA based healthcare and pharmaceutical multi-national company.

BMS is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Company has over 32,200 employees as on 2021. Headquarters is in USA.

BMS discover, develop and deliver innovative medicines that help patients prevail over serious diseases

BMS be the biopharma company that transforms patients' lives through science.

Facts About Company

As on 2022, Bristol-Myers Squibb has 34,300 employees.

Bristol-Myers Squibb annual revenue generated for period ending Dec-2022 was 46,159 million USD.

Bristol-Myers Squibb annual net income generated for period ending Dec-2022 was 6,327 million USD.

As on 2021, BMS had strong financial results with total revenues growing 9 percent year-over-year to $46.4 billion.

Bristol-Myers Squibb annual revenue generated for period ending Dec-2021 was 46,385 million USD.

Split of Regional Revenue by business segment for period ending Dec-2021:

United States: 29,214 million USD.
Europe: 10,687 million USD.
Rest Of The World: 5,632 million USD.
Others: 852 million USD.

Bristol-Myers Squibb annual net income generated for period ending Dec-2021 was 6,994 million USD.

Total Assets as on Dec-2021 was 118,481 Million USD.

Annual Results Summary

BRISTOL-MYERS SQUIBB COMPANY - Annual Revenue and Net Profit - in Million USD:

Year - Ending	Revenue	Net Profit
Dec-2023	45,006	8,025
Dec-2022	46,159	6,327
Dec-2021	46,385	6,994
Dec-2020	42,518	-9,015 (Loss)
Dec-2019	26,145	3,439
Dec-2018	22,561	4,920
Dec-2017	20,776	1,007
Dec-2016	19,427	4,457

Balance Sheet Summary

BRISTOL-MYERS SQUIBB COMPANY - Balance Sheet Summary - in Million USD:

Year Ending:	Total Assets	Total Liabilities	Total Equity
Dec-2023	95,159	65,674	29,485
Dec-2022	96,820	65,702	31,118
Dec-2021	109,314	73,308	36,006
Dec-2020	118,481	80,659	37,822
Dec-2019	129,944	78,346	51,598
Dec-2018	34,986	20,955	14,031
Dec-2017	33,551	21,810	11,741
Dec-2016	33,707	17,530	16,177

Founded Year

1887

Institutional Investors

Top 30 Institutional Holder Names in BRISTOL-MYERS SQUIBB COMPANY as on SEP-30-2023

RANK	INSTITUTION NAME	DATE	SHARES HELD	CHANGE (SHARES)	CHANGE (%)	VALUE (IN 1,000S)
1	VANGUARD GROUP INC	09/30/2023	8,20,76,195	3,65,388	0.45%	$12,523,186
2	BLACKROCK INC.	09/30/2023	7,32,03,465	-8,41,390	-1.14%	$11,169,385
3	STATE STREET CORP	09/30/2023	5,46,80,602	2,38,987	0.44%	$8,343,166
4	GEODE CAPITAL MANAGEMENT, LLC	09/30/2023	1,75,62,102	8,60,209	5.15%	$2,679,626
5	MORGAN STANLEY	09/30/2023	1,62,57,789	19,19,490	13.39%	$2,480,613
6	BANK OF AMERICA CORP /DE/	09/30/2023	1,54,94,499	65,18,337	72.62%	$2,364,151
7	NORTHERN TRUST CORP	09/30/2023	99,70,674	4,04,948	4.23%	$1,521,325
8	BANK OF NEW YORK MELLON CORP	09/30/2023	86,91,369	8,07,357	10.24%	$1,326,129
9	JPMORGAN CHASE & CO	09/30/2023	81,46,857	-3,08,124	-3.64%	$1,243,047
10	AMERIPRISE FINANCIAL INC	09/30/2023	78,99,931	-33,991	-0.43%	$1,205,371
11	AMUNDI	09/30/2023	78,95,453	28,16,469	55.45%	$1,204,688
12	LEGAL & GENERAL GROUP PLC	09/30/2023	64,07,873	-2,43,965	-3.67%	$977,713
13	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	09/30/2023	64,04,186	6,386	0.10%	$977,151
14	CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	09/30/2023	63,45,842	8,71,247	15.91%	$968,249
15	NORGES BANK	12/31/2022	62,17,715	-15,31,992	-19.77%	$948,699
16	UBS ASSET MANAGEMENT AMERICAS INC	09/30/2023	53,69,256	6,81,226	14.53%	$819,241
17	FMR LLC	09/30/2023	52,10,662	-11,26,109	-17.77%	$795,043
18	ROYAL BANK OF CANADA	09/30/2023	48,86,256	-2,02,737	-3.98%	$745,545
19	GOLDMAN SACHS GROUP INC	09/30/2023	45,09,349	-2,16,565	-4.58%	$688,036
20	DIMENSIONAL FUND ADVISORS LP	09/30/2023	44,02,702	-1,06,011	-2.35%	$671,764
21	INVESCO LTD.	09/30/2023	43,71,732	-2,14,648	-4.68%	$667,039
22	WELLS FARGO & COMPANY/MN	09/30/2023	43,14,764	-3,35,206	-7.21%	$658,347
23	NUVEEN ASSET MANAGEMENT, LLC	09/30/2023	37,79,600	-1,01,503	-2.62%	$576,691
24	FIRST TRUST ADVISORS LP	09/30/2023	34,87,315	-4,01,812	-10.33%	$532,095
25	SWISS NATIONAL BANK	09/30/2023	29,20,700	-3,55,400	-10.85%	$445,640
26	SUMITOMO MITSUI TRUST HOLDINGS, INC.	09/30/2023	26,97,077	-43,430	-1.59%	$411,520
27	BARCLAYS PLC	09/30/2023	26,95,770	4,78,109	21.56%	$411,321
28	CREDIT SUISSE AG/	09/30/2023	26,27,490	-7,302	-0.28%	$400,902
29	FRANKLIN RESOURCES INC	09/30/2023	26,13,390	10,604	0.41%	$398,751
30	DEUTSCHE BANK AG\	09/30/2023	25,96,526	-3,80,604	-12.78%	$396,178